News

Waters Elevates Mass Spectrometry Standards with Xevo TQ Absolute XR

Waters Elevates Mass Spectrometry Standards with Xevo TQ Absolute XR

Waters Introduces the Xevo TQ Absolute XR Mass Spectrometer

Waters Corporation has made a significant advancement in mass spectrometry with the introduction of the Xevo TQ Absolute XR Mass Spectrometer. This state-of-the-art device represents a leap forward in both robustness and sensitivity, particularly tailored for high-throughput laboratories. Designed to enhance performance for various applications, including pharmaceutical quantitation and PFAS detection, the Xevo TQ Absolute XR is engineered to meet the evolving demands of scientific research.

Enhanced Performance and Efficiency

The Xevo TQ Absolute XR is built on the trusted legacy of the Xevo TQ Absolute, which has already set high standards in the industry for tandem quadrupole sensitivity. It boasts a remarkable up to six-fold increase in performance robustness thanks to its innovative StepWave™ XR Ion Guide technology. This advancement not only enhances sensitivity but also significantly minimizes the risk of unplanned downtime, ensuring that laboratories can efficiently conduct their analyses without interruptions.

Reduced Environmental Impact

This new Mass Spectrometer operates with an impressive reduction in energy consumption. Using up to 50% less power and nitrogen gas, and generating half the heat compared to competitors, it occupies less bench space, positioning the Xevo TQ Absolute XR as the ideal choice for labs committed to sustainability.

Innovative Applications and Real-World Experience

In the words of James Hallam, Vice President of Liquid Chromatography-Mass Spectrometry at Waters Corporation, today's analytical laboratories are pressed to adapt to complex needs, especially in response to the rising demand for PFAS testing due to shifting regulatory requirements. The Xevo TQ Absolute XR provides unparalleled robustness and remarkable sensitivity, enabling laboratories to meet these challenges effectively.

Sally Hannam, Scientific Director at Synexa Life Sciences, highlights how the Xevo TQ Absolute XR integrates seamlessly into their workflow, stating that the system has facilitated over 20,000 continuous injections of human plasma while maintaining the highest levels of reproducibility and accuracy. This reliability allows them to handle increasingly challenging bioanalysis applications confidently.

Industry-Leading Sensitivity

With the Xevo TQ Absolute XR, labs can achieve industry-leading results in quantifying negatively ionizing compounds, making it essential for bioanalytical, food safety, and environmental testing. The heightened efficiency and trust in its results empower laboratories to excel in their operations, ensuring robust outcomes.

Ordering Information

The Xevo TQ Absolute XR Mass Spectrometer is now available for order, representing a new benchmark in analytical performance that is sure to enhance laboratory capabilities.

Frequently Asked Questions

What is the Xevo TQ Absolute XR Mass Spectrometer?

The Xevo TQ Absolute XR is a mass spectrometer designed by Waters Corporation, enhancing sensitivity and robustness for high-throughput laboratories.

How does the Xevo TQ Absolute XR improve efficiency?

It significantly reduces power and gas usage, occupies less bench space, and enhances operational uptime by minimizing unplanned downtime.

What are its main applications?

The instrument excels in pharmaceutical quantitation, PFAS detection, bioanalysis, and environmental testing processes.

Who can benefit from using this mass spectrometer?

Pharmaceutical companies, contract testing organizations, and government laboratories focused on high-throughput analysis will benefit!

How has the Xevo TQ Absolute XR performed in real laboratory settings?

Early experiences reported extensive injection capabilities with increased reproducibility and confidence in challenging bioanalytical applications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 145

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 175

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 630

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 0

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 777

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Challenges Facing Halliburton Amidst Analyst Concerns

Updated Category News Views 210

Challenges for Halliburton in Today’s Market Recently, Halliburton Company (NYSE: HAL) encountered a significant challenge when a cyberattack interrupted its key business applications, leading to rising concerns among shareholders. Market Position and Diversification Analysts from RBC Capital Markets are pointing out that Halliburton's reliance on a limited range of...

Continue Reading
Wildermuth Fund Investors Urged to Act Before Deadline

Updated Category News Views 155

Crucial Action for Investors in Wildermuth Fund Investors associated with the Wildermuth Fund are facing a pivotal moment as a significant deadline looms. Financial losses sustained from the Fund's recent performance have raised alarm bells, prompting attention from legal experts. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims on...

Continue Reading
Innovative ShieldCRS Platform Earns Cybersecurity Recognition

Updated Category News Views 131

Alchemi's ShieldCRS Platform Achieves Prestigious Award Alchemi Data Management Inc. has recently announced the recognition of its ShieldCRS platform at the Cybersecurity Excellence Awards, which honors the best in the cybersecurity industry. The platform has set itself apart in the category of Insider Threat Protection, demonstrating its capability to provide robust...

Continue Reading
Transforming Urban Spaces: Alliance REIT's Sustainable Vision

Updated Category News Views 188

Revitalizing Urban Neighborhoods with Alliance REIT In recent years, urban developers have faced challenges with vacant properties and rising construction costs. Alliance REIT has taken a proactive approach to address these issues by rejuvenating Toronto's historic buildings and converting them into boutique multiplexes. With an innovative outlook and a commitment to...

Continue Reading
Zelluna ASA Raises NOK 58 Million to Advance Novel Therapy

Updated Category News Views 210

Zelluna ASA Secures Funding for Innovative Cancer Therapy Zelluna ASA has successfully completed a private placement and retail offering, raising NOK 58 million to move forward with ZI-MA4-1, the first "off-the-shelf" TCR-NK therapy for treating cancer. This initiative has garnered strong backing from shareholders, management, and board members, all of whom bring...

Continue Reading